IT1167610B - Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione - Google Patents

Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione

Info

Publication number
IT1167610B
IT1167610B IT47570/83A IT4757083A IT1167610B IT 1167610 B IT1167610 B IT 1167610B IT 47570/83 A IT47570/83 A IT 47570/83A IT 4757083 A IT4757083 A IT 4757083A IT 1167610 B IT1167610 B IT 1167610B
Authority
IT
Italy
Prior art keywords
interfreron
pharmaceutical composition
composition containing
production process
multiclass hybrid
Prior art date
Application number
IT47570/83A
Other languages
English (en)
Other versions
IT8347570A0 (it
Inventor
David F Mark
Abla A Creasey
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of IT8347570A0 publication Critical patent/IT8347570A0/it
Application granted granted Critical
Publication of IT1167610B publication Critical patent/IT1167610B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT47570/83A 1982-01-19 1983-01-18 Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione IT1167610B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34078282A 1982-01-19 1982-01-19

Publications (2)

Publication Number Publication Date
IT8347570A0 IT8347570A0 (it) 1983-01-18
IT1167610B true IT1167610B (it) 1987-05-13

Family

ID=23334917

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47570/83A IT1167610B (it) 1982-01-19 1983-01-18 Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione

Country Status (5)

Country Link
US (2) US4569908A (it)
EP (1) EP0098876A1 (it)
CA (1) CA1210715A (it)
IT (1) IT1167610B (it)
WO (1) WO1983002461A1 (it)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
GB8317880D0 (en) * 1983-07-01 1983-08-03 Searle & Co Structure and synthesis of interferons
GB8334102D0 (en) * 1983-12-21 1984-02-01 Searle & Co Interferons with cysteine pattern
GB8412564D0 (en) * 1984-05-17 1984-06-20 Searle & Co Structure and properties
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
US4716217A (en) * 1984-08-31 1987-12-29 University Patents, Inc. Hybrid lymphoblastoid-leukocyte human interferons
US4734491A (en) * 1984-08-31 1988-03-29 University Patents, Inc. DNA sequences encoding hybrid lymphoblastoid-leukocyte human interferons
DE3432196A1 (de) * 1984-09-01 1986-03-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neues mechanisches aufschlussverfahren von bakterienzellen zur isolierung von rekombinant hergestellten peptiden
DE3511011A1 (de) * 1985-03-27 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur isolierung und reinigung von (alpha)-interferonen
EP0205404B1 (en) * 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid interferons
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
US6150503A (en) * 1988-10-28 2000-11-21 Pestka Biomedical Laboratories, Inc. Phosphorylated fusion proteins
IL92124A (en) 1988-10-28 1996-10-31 Sidney Pestka Recombinant proteins modified to contain post-phosphorylation that do not occur in nature
US6747131B1 (en) 1988-10-28 2004-06-08 Pestka Biomedical Laboratories, Inc. Phosphorylated fusion proteins
US5705363A (en) * 1989-03-02 1998-01-06 The Women's Research Institute Recombinant production of human interferon τ polypeptides and nucleic acids
WO1990012877A1 (en) * 1989-04-19 1990-11-01 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5939286A (en) * 1995-05-10 1999-08-17 University Of Florida Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
US6800747B1 (en) 1995-06-07 2004-10-05 Pestka Biomedical Laboratories, Inc. Nucleic acids encoding phosphorylated fusion proteins
US6204022B1 (en) * 1996-04-12 2001-03-20 Pepgen Corporation And University Of Florida Low-toxicity human interferon-alpha analogs
US6685933B1 (en) 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
SI1121382T1 (sl) * 1998-10-16 2007-02-28 Biogen Idec Inc Fuzijski proteini interferona-beta in uporabe
CN100480266C (zh) * 1998-10-16 2009-04-22 拜奥根Idec马萨诸塞公司 干扰素-β融合蛋白及用途
LT2599503T (lt) 1998-10-16 2017-06-26 Biogen Ma Inc. Interferono beta-1a polimero konjugatai ir jų panaudojimas
JP2003530838A (ja) 2000-04-12 2003-10-21 ヒューマン ゲノム サイエンシズ インコーポレイテッド アルブミン融合タンパク質
FR2817559B1 (fr) * 2000-12-06 2003-12-12 Genodyssee Procede de determination d'un ou plusieurs polymorphisme(s) fontionnel(s) dans la sequence nucleique d'un gene "candidat" fonctionnel preselectionne et ses applications
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
FR2824333B1 (fr) * 2001-05-03 2003-08-08 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 5
CN1568369A (zh) 2001-08-12 2005-01-19 派普根公司 杂合的干扰素/干扰素Tau蛋白、组合物和使用方法
KR101271635B1 (ko) * 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
CA2471363C (en) 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
US20080194481A1 (en) * 2001-12-21 2008-08-14 Human Genome Sciences, Inc. Albumin Fusion Proteins
DE60332556D1 (de) * 2002-05-01 2010-06-24 Danisco Us Inc Cytokine und cytokinrezeptoren mit reduzierter immunogenität
US20040175359A1 (en) * 2002-11-12 2004-09-09 Desjarlais John Rudolph Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
EP1753779A2 (en) 2004-05-19 2007-02-21 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
US20080292586A1 (en) * 2005-02-04 2008-11-27 Karen Jervis Method and Use of Interferon Compositions For the Treatment of Avian Influenza
MX2007014524A (es) 2005-05-18 2008-02-07 Maxygen Inc Polipeptidos desarrollados de interferon-alfa.
DOP2006000117A (es) * 2005-05-19 2007-11-30 Schering Ag Terapia génica de interferon-beta usando un sistema mejorado de expresión regulada
EP1885858A2 (en) * 2005-05-19 2008-02-13 Bayer Schering Pharma Aktiengesellschaft Treatment of disease using an improved regulated expression system
US20080076729A1 (en) * 2005-05-19 2008-03-27 Schering Aktiengesellachaft Interferon-beta gene therapy using an improved, regulated expression system
US20070179113A1 (en) * 2005-05-19 2007-08-02 Schering Aktiengesellachaft GM-CSF gene therapy for Crohn's disease using an improved regulated expression system
WO2007146038A2 (en) 2006-06-07 2007-12-21 Human Genome Sciences, Inc. Albumin fusion proteins
WO2008125222A2 (en) * 2007-04-11 2008-10-23 Bayer Schering Pharma Aktiengesellschaft New modulation molecules for an improved regulated expression system
EP2076533B1 (en) * 2007-05-02 2014-10-08 Ambrx, Inc. Modified interferon beta polypeptides and their uses
US8273561B2 (en) * 2007-10-05 2012-09-25 Nuron Biotech, Inc. High pressure treatment of aggregated interferons
MX2012008893A (es) * 2010-02-01 2013-02-27 Digna Biotech Sl Procedimiento para la produccion de interferon alfa 5.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
US4456748A (en) * 1981-02-23 1984-06-26 Genentech, Inc. Hybrid human leukocyte interferons
ES8302778A1 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
US4414150A (en) * 1980-11-10 1983-11-08 Genentech, Inc. Hybrid human leukocyte interferons
US4678751A (en) * 1981-09-25 1987-07-07 Genentech, Inc. Hybrid human leukocyte interferons

Also Published As

Publication number Publication date
CA1210715A (en) 1986-09-02
IT8347570A0 (it) 1983-01-18
US4758428A (en) 1988-07-19
EP0098876A1 (en) 1984-01-25
WO1983002461A1 (en) 1983-07-21
US4569908A (en) 1986-02-11

Similar Documents

Publication Publication Date Title
IT1167610B (it) Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione
NL930032I2 (nl) 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydronafyridine-3-carbozuren, werkwijzen ter bereiding ervan en deze bevattende geneesmiddelen.
FI841522A (fi) Processtyrsystem med felsoekning.
DE3382738D1 (de) Hydrokrackverfahren.
NL186912B (nl) Kleefmiddelsamenstelling en voorwerpen die de kleefmiddelsamenstelling bevatten.
IT8026423A0 (it) Processo per la preparazione di polimeri contenenti amino-amidi.
NL8300934A (nl) Gesubstitueerde 1h-pyrazolo1,5-a-pyrimidinen, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten, die deze verbindingen bevatten.
IT1167123B (it) Benzoazacicloalchilspiro-imidazolidine,procedimento per prepararle e composizioni farmaceutiche che le contengono
FI841009A (fi) Kemisk process.
GB2019837A (en) N-Oxacyclic-alkylpiperidyl-diazacompounds, process for their manufacture and pharmaceutical compositions containing them
DE3381088D1 (de) Polymerisationsverfahren.
DK312084D0 (da) En forbedret proces
FI74028B (fi) Process foer tillverkning av aromatiska polyestrar.
NL188654B (nl) Polycarbonaat bevattende, thermoplastische vormsamenstelling.
DE3375914D1 (en) Novel 5-membered cyclic compounds, process for the production thereof, and pharmaceutical use thereof
DE3163199D1 (en) Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
IT7825220A0 (it) Benzilpirimidine, processo per laloro preparazione e farmaci che le contengono.
IT7925761A0 (it) Processo per la preparazione di l-alfa-glicerilfosforilcolina.
IT8324390A0 (it) Procedimento perfezionato di atomizzazione rotativa.
FI834004A (fi) Autoradiografisk process
IT8621857A0 (it) Cinnamilammine, processo per laloro preparazione e composizioni farmaceutiche che le contengono.
IT8321732A0 (it) Apparecchio di diluizione, specialmente per la fabbricazione di medicinali omeopatici.
IT7819905A0 (it) Pirimidilsolfuri ad attivita'antisecretoria, processo per laloro preparazione e composizioni farmaceutiche che li contengono.
FI831005L (fi) Foerfarande foer anaerob rening av furfurolhaltiga avfallsvatten, bakterier anvaendbara i foerfaranoch aotervinning daerav
IT8348886A0 (it) Acetanilidi basiche, procedimento per la loro produzione e medicamenti che le contengono

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940225